Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4077772rdf:typepubmed:Citationlld:pubmed
pubmed-article:4077772lifeskim:mentionsumls-concept:C0017535lld:lifeskim
pubmed-article:4077772lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:4077772lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:4077772lifeskim:mentionsumls-concept:C0048576lld:lifeskim
pubmed-article:4077772lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:4077772pubmed:issue5lld:pubmed
pubmed-article:4077772pubmed:dateCreated1986-2-20lld:pubmed
pubmed-article:4077772pubmed:abstractTextThe activities of 11 5-nitroimidazole compounds have been compared against Giardia intestinalis in vitro using a 3H-thymidine incorporation assay. All the compounds were at least equipotent to, or more active than metronidazole with the exception of panidazole. Satranidazole, ronidazole and S75 0400 A were all about five times more active than metronidazole and warrant further study as potential chemotherapeutic agents for man. No major differences in the response to these compounds was found between two stocks of Giard. intestinalis with the exception of flunidazole. Several other antiprotozoal drugs showed activity against Giard. intestinalis. Berberine sulphate, paromomycin sulphate, erythromycin estolate and sulphasalazine, all of which have been used to treat human patients, showed no activity in vitro.lld:pubmed
pubmed-article:4077772pubmed:languageenglld:pubmed
pubmed-article:4077772pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4077772pubmed:citationSubsetIMlld:pubmed
pubmed-article:4077772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4077772pubmed:statusMEDLINElld:pubmed
pubmed-article:4077772pubmed:monthNovlld:pubmed
pubmed-article:4077772pubmed:issn0305-7453lld:pubmed
pubmed-article:4077772pubmed:authorpubmed-author:BorehamP FPFlld:pubmed
pubmed-article:4077772pubmed:authorpubmed-author:ShepherdR WRWlld:pubmed
pubmed-article:4077772pubmed:authorpubmed-author:PhillipsR ERElld:pubmed
pubmed-article:4077772pubmed:issnTypePrintlld:pubmed
pubmed-article:4077772pubmed:volume16lld:pubmed
pubmed-article:4077772pubmed:ownerNLMlld:pubmed
pubmed-article:4077772pubmed:authorsCompleteYlld:pubmed
pubmed-article:4077772pubmed:pagination589-95lld:pubmed
pubmed-article:4077772pubmed:dateRevised2010-4-12lld:pubmed
pubmed-article:4077772pubmed:meshHeadingpubmed-meshheading:4077772-...lld:pubmed
pubmed-article:4077772pubmed:meshHeadingpubmed-meshheading:4077772-...lld:pubmed
pubmed-article:4077772pubmed:meshHeadingpubmed-meshheading:4077772-...lld:pubmed
pubmed-article:4077772pubmed:meshHeadingpubmed-meshheading:4077772-...lld:pubmed
pubmed-article:4077772pubmed:year1985lld:pubmed
pubmed-article:4077772pubmed:articleTitleA comparison of the in-vitro activity of some 5-nitroimidazoles and other compounds against Giardia intestinalis.lld:pubmed
pubmed-article:4077772pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:4077772pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:4077772pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:4077772pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:4077772pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4077772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4077772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4077772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4077772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4077772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4077772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4077772lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:4077772lld:pubmed